Ikarian Capital LLC 13D and 13G filings for Millendo Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 4:31 pm Sale |
2021-12-31 | 13G | Millendo Therapeutics, Inc. MLND |
Ikarian Capital LLC | 58,803 0.900% |
-31,065 (-34.57%) |
Filing |
| 2021-04-07 5:25 pm Purchase |
2021-03-18 | 13G | Millendo Therapeutics, Inc. MLND |
Ikarian Capital LLC | 89,868 7.100% |
89,868 (New Position) |
Filing |